Maxion Therapeutics
Entity

  • Maxion Therapeutics

    Created in 2020


  • Up & running (A)
    Existing signals show a regular activity

  • Social networks

    35 4,956

  • Activities

    deeptech biotech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    Unity Campus, Cambridge CB22 3FT, UK

    Cambridge

    United Kingdom

  • Employees

    Scale: 11-50

    Estimated: 35

  • Engaged corporates

    1
    0 0

  • Added in Motherbase

    2 years ago
Description
  • Value proposition

    Ion channel and GPCR drug discovery using innovative KnotBody technology

    Maxion uses its innovative KnotBody technology in combination with in vitro display technologies to generate therapeutic candidates against ion channels and GPCR proteins.

  • Maxion® Therapeutics | Home

    Maxion Therapeutics | We are using our revolutionary KnotBody® technology to create first-in-class and best-in-class protein therapeutics for treating previously untreatable ion channel- and GPCR-driven diseases.

    • https://www.maxiontherapeutics.com/
Corporate interactions
Corporate TypeTweets Articles
AstraZeneca
AstraZeneca
Pharmaceutical, Pharmaceutical Manufacturing
AstraZeneca
Pharmaceutical, Pharmaceutical Manufacturing 		Other

3 May 2024


Similar entities
Last news
Show all articles
Social network dynamics